> IMHO, the solution is actually less regulation.
> If any company could enter that market with being sued into the ground, you'd get top notch a quality product for a fraction of the price before you could finish spelling epinephrine.
I doubt it. IIRC, EpiPens are off-patent, and the only thing holding back competition is the need to demonstrate the competing product is safe, reliable, and equivalent. I even believe a competitor product was withdrawn from the market because it was delivering an unreliable dosage.
So if you remove the regulations, you'll probably get a flood of corner-cutting crap that's dangerous. That's likely especially true for an emergency use item like an EpiPen, which literally sits on a shelf unused unless there's an emergency (leaving a big opportunity to sell defective items undetected by consumers).
